HOME >> MEDICINE >> NEWS
Scientist explain a drug's paradoxical action: discovery may lead to new therapies for breast cancer, early puberty

What could be the explanation for a drug that works at low doses to help children with one type of early puberty - but requires doses ten times higher to treat a similar disease? For years, this puzzle has intrigued pediatric endocrinologists, the doctors who care for children with abnormal hormone systems.

Now scientists at UC San Francisco, working with a new experimental model that turns yeast cells into little versions of human adrenal glands, have learned the answer: they have shown how the drug, medroxyprogesterone acetate (MPA) inhibits one of the key enzymes necessary to produce steroid hormones.

MPA more commonly is known by its brand name, Provera. Often prescribed as a hormone replacement therapy during menopause, it sometimes is used to treat small children who develop breasts, enlarged testicles and other sex characteristics. In high doses it is used to treat women with breast cancer.

The research, published in the June issue of The Journal of Clinical Endocrinology and Metabolism, was conducted by second year Tufts University medical student Tim Lee and UCSF research scientist Richard Auchus, MD, PhD, in the laboratory of Walter L. Miller, MD, UCSF professor of pediatric endocrinology. The study, conducted on a summer research grant from the Society for Pediatric Research (SPR), earned Lee a prestigious Medical Student Research Award at the annual meeting of the Society for Pediatric Research in May. Lee and Auchus were looking for a way to explain MPA's dual mechanism of action. Normally, puberty starts in the pre-teen years, when certain cells in the brain begin pulsing out small timed doses of a chemical signal called GnRH, for gonadotropin releasing hormone. GnRH instructs the ovaries and testes to start making steroids, including sex hormones. For children who start to develop sex characteristics very early - as young as toddler age - Provera is one of a number of drugs that can be used to delay the onset of puberty. Scientists al
'"/>

Contact: Janet Basu
jbasu@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
8-Jun-1999


Page: 1 2 3 4

Related medicine news :

1. Scientist works on innovative treatments for brain tumors
2. Scientists replicate hepatitis C virus in laboratory
3. Scientists identify brain regions that decide where we look
4. Scientists uncover new mechanism for the amygdala in fear recognition
5. Scientists identify protein critical to melanoma growth
6. Scientists discover recipe for life: eating the Polymeal cuts heart disease by 76%
7. Scientists study fish oil diet in bid to cut heart attack risks
8. Scientists discover enzyme crucial to the transportation of proteins within cells
9. Scientists turn on the gender lens on cardiovascular disease research
10. Scientists stalk PPAR-gamma, find novel cancer connection
11. Scientists align billion-year-old protein with embryonic heart defects

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... ... "Pacifica Experience" Open House day on Pacifica's Lambert Campus, 249 Lambert Road, ... Depth Psychology, the Humanities, Clinical Psychology, Counseling Psychology, and Mythological Studies. Program ...
(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... ... , ... A September 2 article on CBS News details a ... likely to suffer heart attacks, strokes, kidney failure, and heart disease versus a control ... surgery specialists Dr. Feiz and Associates says the study adds further evidence to an ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... will exhibit at the 2019 AHIMA Health Data and Information Conference in Chicago, ... stop by booth #505 to learn more about GRM’s healthcare information management ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... challenges facing specialty healthcare, announces the issuance of a patent to reduce the ... payment plan for both time-of-service and post visit patient statements. , At the ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... (PRWEB) , ... September 14, 2019 , ... ... of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County found ... consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J talc ...
(Date:9/12/2019)... CITY (PRWEB) , ... September 12, 2019 , ... ... are collaborating to help make the services of CPESN’s clinically integrated network of ... and payers. CPESN USA’s participating pharmacies provide high quality clinical service programs ...
(Date:9/11/2019)... FALLS CHURCH, Va. (PRWEB) , ... September 11, ... ... explosion is revolutionizing image analysis, with many companies developing technologies to evaluate medical ... segments. , Unless one understands the approaches the FDA is taking to AI-based ...
Breaking Medicine Technology:
Cached News: